NPI: 1689229353 · RENO, NV 89503 · Emergency Medicine Physician · NPI assigned 08/08/2019
Authorized official FILTON, STEVE controls 20+ related entities in our dataset. Read more
| Authorized Official | FILTON, STEVE (EXECUTIVE VP-CFO) |
| Parent Organization | SPARKS FAMILY HOSPITAL INC |
| NPI Enumeration Date | 08/08/2019 |
Other providers sharing the same authorized official: FILTON, STEVE
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 141 | $398.51 |
| 2021 | 11,372 | $187K |
| 2022 | 10,940 | $244K |
| 2023 | 10,101 | $259K |
| 2024 | 6,156 | $184K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 3,157 | 2,650 | $237K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 4,178 | 3,613 | $209K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1,860 | 1,545 | $168K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1,350 | 1,137 | $39K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1,558 | 1,243 | $37K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 173 | 155 | $36K |
| 96375 | Therapeutic injection; each additional sequential IV push | 949 | 759 | $17K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 577 | 534 | $17K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 382 | 316 | $15K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,042 | 880 | $13K |
| 80053 | Comprehensive metabolic panel | 2,420 | 1,946 | $10K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2,749 | 2,231 | $8K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1,028 | 822 | $8K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 320 | 300 | $7K |
| 71045 | Radiologic examination, chest; single view | 1,116 | 945 | $7K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 592 | 495 | $5K |
| 36415 | Collection of venous blood by venipuncture | 3,191 | 2,549 | $4K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 910 | 416 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 913 | 743 | $3K |
| 83690 | 1,147 | 938 | $3K | |
| 84484 | 603 | 398 | $2K | |
| 81001 | 1,334 | 1,113 | $2K | |
| 84703 | 473 | 402 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 334 | 290 | $2K |
| 87430 | 254 | 236 | $2K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1,136 | 1,017 | $1K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 87 | 72 | $1K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 73 | 68 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 396 | 339 | $1K |
| 81025 | 448 | 398 | $1K | |
| 71046 | Radiologic examination, chest; 2 views | 109 | 97 | $1K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,394 | 1,192 | $1K |
| 87070 | 255 | 235 | $1K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 36 | 29 | $929.84 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 189 | 163 | $669.90 |
| 81003 | 491 | 394 | $421.52 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 459 | 414 | $400.59 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 19 | 16 | $355.95 |
| 83605 | 55 | 38 | $225.17 | |
| 87420 | 34 | 28 | $214.18 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 717 | 568 | $186.52 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 19 | 12 | $180.46 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 20 | 12 | $173.10 |
| 87077 | 14 | 12 | $139.63 | |
| 87186 | 27 | 24 | $98.81 | |
| 84443 | Thyroid stimulating hormone (TSH) | 16 | 12 | $76.87 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 34 | 13 | $48.63 |
| 85027 | 20 | 13 | $26.52 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 14 | 14 | $10.10 |
| J2060 | Injection, lorazepam, 2 mg | 14 | 13 | $6.19 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 24 | 17 | $3.14 |